TerminatedNCT02839798
NeoSync TMS Treatment for Bipolar I Depression
Device studyAges 18–70United StatesBipolarity
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- ProvidenceSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2016
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 6
- Sponsor
- Butler Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02839798
- Official title
Show the full official title
Evaluation of NeoSync EEG Synchronized TMS For the Treatment of Major Depressive Episode in Bipolar Disorder and Associated Neural Response: An Open Label Trial
Recruitment & locations
TerminatedProvidence
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Butler Hospital, a hospital or academic medical center.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
